Clinical Trials Directory

Trials / Completed

CompletedNCT02373982

Left Atrial Geometry and Outcomes After Atrial Fibrillation Ablation

External Validation of the Left Atrial Sphericity as Predictor of Recurrence After Atrial Fibrillation Ablation: A Multicenter Observational Study.

Status
Completed
Phase
Study type
Observational
Enrollment
417 (actual)
Sponsor
Hospital Clinic of Barcelona · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a Multicenter Observational 1-year retrospective cohort study evaluating the predictive value of the Left Atrial Sphericity on the recurrence rate of atrial fibrillation after pulmonary vein ablation procedure. Inclusion of consecutive patients undergoing AF ablation during 2013 in whom a 3D-imaging of the left atrium (Cardiac CT or MRA) was acquired prior to the procedure and when procedural/follow-up data was prospectively collected.

Detailed description

Validation of the predictive value of the Left Atrial Sphericity for AF recurrence of atrial fibrillation after a pulmonary vein ablation procedure in an external, multicenter cohort. In total, 9 centers will include consecutive patients who underwent AF ablation from january to december 2013 in whom a 3D-imaging of the left atrium (Cardiac CT or MRA) was acquired prior to the procedure and when procedural/follow-up data was prospectively collected.

Conditions

Timeline

Start date
2013-01-01
Primary completion
2014-12-01
Completion
2017-04-01
First posted
2015-02-27
Last updated
2017-04-11

Locations

9 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT02373982. Inclusion in this directory is not an endorsement.